Impact of marketing costs and the research and development on the profitability of Egypt's pharmaceutical companies

Abstract EN

The main objective of this study is to examine the impact of marketing and R&D expenditures on the competitiveness of Egypt's pharmaceutical companies.

In this report, Egypt Stock Exchange admitted pharmaceutical companies.

Data estimator random-effect panel was used for this purpose.

The results indicate that variables such as the size of a business, the capital-to-total ratio of assets and the debt-to-asset ratio affect profitability.

Nonetheless, on competitiveness, business life, advertisement costs and spending in R&D are unsuccessful.

Legal concerns such as the ence of patent law and the framework for pricing are reasons for the poor partnership between R&D and marketing costs and its effect on income, The results indicate that variables such as the size of a business, the capital--ratio of assets and the debt--ratio affect profitability.

Nonetheless, on competitiveness, business life, advertisement costs and spending in R&D are unsuccessful.

Regulatory problems including the lack of & ence of patent law and pricing controls are reasons for the poor partnership between R&D and marketing costs and its impact on the Egyptian pharmaceutical industry's profitability.